Amicus Therapeutics to Present at Oppenheimer Healthcare Conference

CRANBURY, N.J., Dec. 4, 2014 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Chip Baird, Chief Financial Officer, will present a corporate overview at the 25th Annual Oppenheimer Healthcare Conference in New York, NY on Thursday, December 11, 2014 at 1:35 p.m. ET.

A live webcast of the presentation can be accessed through the Investors section of the Amicus Therapeutics corporate web site at http://ir.amicustherapeutics.com/events.cfm, and will be archived for 90 days.  

About Amicus Therapeutics

Amicus Therapeutics (Nasdaq: FOLD) is a biopharmaceutical company at the forefront of therapies for rare and orphan diseases. The Company is developing novel, first-in-class treatments for a broad range of human genetic diseases, with a focus on delivering new benefits to individuals with lysosomal storage diseases. Amicus' lead programs include the small molecule pharmacological chaperones migalastat as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease; and AT2220 (duvoglustat) in combination with ERT for Pompe disease.

FOLD-G

CONTACT: Sara Pellegrino
         Director, Investor Relations
         [email protected]
         (609) 662-5044

Source: Amicus Therapeutics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Form 8.3 - Mattioli Woods PLC
• Alliance Trust PLC - Net Asset Value
• Form 8.3 - Lok’n Store Group PLC